Regency Centers CEO gets 17,934-share stock grant

Regency Centers Corp. reported a new equity award to its President and CEO, Lisa Palmer.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Regency Centers Corp. reported a new equity award to its President and CEO, Lisa Palmer. On February 3, 2026, she received a restricted stock grant covering derivative securities tied to 17,934 shares of common stock at a price of $0 per share.

The filing notes these shares vest in stages, with 25% of the award vesting each year beginning on February 3, 2027. The grant is held directly by Palmer and represents stock-based compensation that increases her beneficial ownership as the shares vest over time.

Insider Trade Summary

Grant/Award: 17,934 shares

Grant/Award 1 txn

Insider PALMER LISA

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Grant	17,934	$0.00	$0.00

Holdings After Transaction: Restricted Stock Grant — 17,934 contracts (Direct)

Footnotes (1)

F1. Shares vest 25% annually beginning February 3, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Regency Centers (REG) report in this Form 4?

Regency Centers reported a restricted stock grant to President and CEO Lisa Palmer. The award covers derivative securities tied to 17,934 shares of common stock at a price of $0 per share, representing stock-based compensation rather than an open-market purchase or sale.

How many shares are included in Lisa Palmer’s restricted stock grant at Regency Centers (REG)?

Lisa Palmer received a restricted stock grant linked to 17,934 shares of Regency Centers common stock. These shares are reported as derivative securities, all held directly, and the same 17,934 shares are listed as beneficially owned following the reported transaction in the Form 4.

What is the vesting schedule for the 17,934 restricted shares at Regency Centers (REG)?

The 17,934 restricted shares vest 25% annually beginning February 3, 2027. This means the award vests in four equal annual installments starting on that date, gradually increasing Lisa Palmer’s fully vested ownership over a multi-year period as each tranche becomes unrestricted.

Who is the insider receiving the restricted stock grant at Regency Centers (REG)?

The recipient is Lisa Palmer, who serves as both President and CEO and a director of Regency Centers. The Form 4 identifies her as the sole reporting person, with the restricted stock grant held directly rather than through an intermediary entity or related person.

Is the Regency Centers (REG) restricted stock grant an acquisition or a sale of securities?

The transaction is classified as an acquisition, coded “A” on the Form 4. It reflects the award of restricted stock as compensation, not a sale or disposition. The report shows 17,934 derivative securities acquired and 17,934 beneficially owned afterward, all directly held.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/05/2026 - 02:12 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PALMER LISA

(Last)

(First)

(Middle)

C/O REGENCY CENTERS CORPORATION

ONE INDEPENDENT DRIVE SUITE 114

(Street)

JACKSONVILLE

32202

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
REGENCY CENTERS CORP [ REG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Grant	⁽¹⁾	02/03/2026		A		17,934		⁽¹⁾	⁽¹⁾	Common Stock	17,934	$0	17,934	D

Explanation of Responses:

1. Shares vest 25% annually beginning February 3, 2027.

Remarks:

	/s/Michael R. Herman Attorney-in-Fact	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR